Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IANALUMAB Cause Diffuse large b-cell lymphoma recurrent? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with IANALUMAB. This represents 45.5% of all adverse event reports for IANALUMAB.

5
Reports of Diffuse large b-cell lymphoma recurrent with IANALUMAB
45.5%
of all IANALUMAB reports
0
Deaths
0
Hospitalizations

How Dangerous Is Diffuse large b-cell lymphoma recurrent From IANALUMAB?

Of the 5 reports.

Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IANALUMAB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does IANALUMAB Cause?

Disease progression (5)

What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?

RITUXIMAB (1,359) CYCLOPHOSPHAMIDE (1,007) VINCRISTINE (957) DOXORUBICIN (953) PREDNISONE (738) CYTARABINE (406) DEXAMETHASONE (402) ETOPOSIDE (375) CISPLATIN (306) GEMCITABINE (280)

Related Pages

IANALUMAB Full Profile All Diffuse large b-cell lymphoma recurrent Reports All Drugs Causing Diffuse large b-cell lymphoma recurrent IANALUMAB Demographics